Showing results (41-50 of 103) with videos related to
Sort By:
Pageof 11
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 27, 2019
Home vs Hospital Infusion of Biologic Agents for Patients With Inflammatory Bowel DiseasesMarc Fenster, Ryan C Ungaro, Robert Hirten, et al.AIDS Patient Care and Stds|August 11, 2016
Challenges in Recruiting People Who Use Drugs for HIV-Related Biomedical Research: Perspectives from the FieldPedro Batista, Sherry Deren, Angela Banfield, et al.Proceedings of the National Academy of Sciences of the United States of America|January 19, 2007
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypesLeonia Bozzacco, Christine Trumpfheller, Frederick P Siegal, et al.Journal of Virology|November 27, 2004
Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10Saurabh Mehandru, Terri Wrin, Justin Galovich, et al.Contemporary Clinical Trials|November 19, 2025
Combination Therapy of Resilience Intervention with Biologics in Crohn's Disease (CATHARSIS): Study protocol for a randomized controlled trialLaurie Keefer, Ryan Ungaro, Ayanna Lewis, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2008
Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical courseNicole Prada, Brandi Davis, Patrick Jean-Pierre, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experienceAnita Shet, Leslie Berry, Hiroshi Mohri, et al.Inflammatory Bowel Diseases|March 20, 2023
Acute Severe Ulcerative Colitis Is Associated With an Increased Risk of Acute PouchitisMaia Kayal, Hannah Posner, Hadar Meringer Milwidsky, et al.European Journal of Immunology|October 18, 2011
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivoAustin Pantel, Cheolho Cheong, Durga Dandamudi, et al.AIDS (London, England)|December 20, 2007
Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety dataBrigitta Vcelar, Gabriela Stiegler, Hermann M Wolf, et al.Pageof 11